NEWS
BeadReady™ & Bioprinting MSC Spheroids
The population of haematopoietic stem cells (HSCs) found in our bone marrow are responsible for repopulating the body with all blood and immune cells throughout our lives. As we age,...
BeadReady™ & Bioprinting MSC Spheroids
The population of haematopoietic stem cells (HSCs) found in our bone marrow are responsible for repopulating the body with all blood and immune cells throughout our lives. As we age,...
Atelerix supports lifetime CDT
The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) is a partnership between the University of Glasgow, University of Birmingham, Aston University...
Atelerix supports lifetime CDT
The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) is a partnership between the University of Glasgow, University of Birmingham, Aston University...
Atelerix presents promising data for the applic...
One of the biggest challenges faced by CAR-T Cell manufactures is the variability among apheresis product, which can negatively impact T Cell manufacturing success and therefore patient treatment. A solution...
Atelerix presents promising data for the applic...
One of the biggest challenges faced by CAR-T Cell manufactures is the variability among apheresis product, which can negatively impact T Cell manufacturing success and therefore patient treatment. A solution...
New distributor agreement between Atelerix and ...
New distributor agreement between Atelerix (UK) and BioBench Solutions LLP (India). We are proud to announce the beginning of a new distribution agreement with BioBench Solutions, who will be distributing...
New distributor agreement between Atelerix and ...
New distributor agreement between Atelerix (UK) and BioBench Solutions LLP (India). We are proud to announce the beginning of a new distribution agreement with BioBench Solutions, who will be distributing...
New patent application published!
Atelerix’s newest patent application extends protection to preserving viruses Atelerix has received notification that its newest patent application has been published pertaining to the STORING AND/OR TRANSPORTING OF EXTRACELLULAR...
New patent application published!
Atelerix’s newest patent application extends protection to preserving viruses Atelerix has received notification that its newest patent application has been published pertaining to the STORING AND/OR TRANSPORTING OF EXTRACELLULAR...
Atelerix launches its new product CytoStor™
We are excited to announce the release of the newest addition in our hypothermic cell and virus preservation range. CytoStor’s cytoprotective capacity can encapsulate up to 10 million cells per...
Atelerix launches its new product CytoStor™
We are excited to announce the release of the newest addition in our hypothermic cell and virus preservation range. CytoStor’s cytoprotective capacity can encapsulate up to 10 million cells per...
